364 related articles for article (PubMed ID: 25751759)
1. Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship.
Christensen JF; Bandak M; Campbell A; Jones LW; Højman P
Acta Oncol; 2015 May; 54(5):592-9. PubMed ID: 25751759
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of advanced testicular cancer.
Feldman DR; Bosl GJ; Sheinfeld J; Motzer RJ
JAMA; 2008 Feb; 299(6):672-84. PubMed ID: 18270356
[TBL] [Abstract][Full Text] [Related]
3. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
Haugnes HS; Bosl GJ; Boer H; Gietema JA; Brydøy M; Oldenburg J; Dahl AA; Bremnes RM; Fosså SD
J Clin Oncol; 2012 Oct; 30(30):3752-63. PubMed ID: 23008318
[TBL] [Abstract][Full Text] [Related]
4. Sequelae of treatment in long-term survivors of testis cancer.
Abouassaly R; Fossa SD; Giwercman A; Kollmannsberger C; Motzer RJ; Schmoll HJ; Sternberg CN
Eur Urol; 2011 Sep; 60(3):516-26. PubMed ID: 21684072
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.
Fung C; Fossa SD; Milano MT; Sahasrabudhe DM; Peterson DR; Travis LB
J Clin Oncol; 2015 Oct; 33(28):3105-15. PubMed ID: 26240226
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Mortality in Testicular Nonseminomatous Germ Cell Tumors: Does Statistical Significance Imply Clinical Significance?
Ramos JD; Yu EY
J Clin Oncol; 2015 Oct; 33(28):3075-7. PubMed ID: 26304903
[No Abstract] [Full Text] [Related]
7. Late adverse effects and quality of life in survivors of testicular germ cell tumour.
Chovanec M; Lauritsen J; Bandak M; Oing C; Kier GG; Kreiberg M; Rosenvilde J; Wagner T; Bokemeyer C; Daugaard G
Nat Rev Urol; 2021 Apr; 18(4):227-245. PubMed ID: 33686290
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Disease Mortality After Diagnosis With Extragonadal Germ Cell Tumors.
Alanee S; Dynda D
J Clin Oncol; 2016 Apr; 34(11):1285. PubMed ID: 26858340
[No Abstract] [Full Text] [Related]
9. Chemotherapy-induced toxicity in patients with testicular germ cell tumors: The impact of physical fitness and regular exercise.
Amiri A; Chovanec M; Oliva V; Sedliak M; Mego M; Ukropec J; Ukropcová B
Andrology; 2021 Nov; 9(6):1879-1892. PubMed ID: 34245663
[TBL] [Abstract][Full Text] [Related]
10. Long-term toxicity of the treatment for germ cell-cancer. A review.
Maroto P; Anguera G; Martin C
Crit Rev Oncol Hematol; 2018 Jan; 121():62-67. PubMed ID: 29279100
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors.
Haugnes HS; Oldenburg J; Bremnes RM
Urol Oncol; 2015 Sep; 33(9):399-406. PubMed ID: 25554583
[TBL] [Abstract][Full Text] [Related]
12. The graying of testis cancer patients: what have we learned?
Bajorin DF
J Clin Oncol; 2007 Oct; 25(28):4341-3. PubMed ID: 17906197
[No Abstract] [Full Text] [Related]
13. Secondary malignant neoplasms in testicular cancer survivors.
Curreri SA; Fung C; Beard CJ
Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
[TBL] [Abstract][Full Text] [Related]
14. Toxicity of treatment of germ cell tumors.
Boyer M; Raghavan D
Semin Oncol; 1992 Apr; 19(2):128-42. PubMed ID: 1313191
[TBL] [Abstract][Full Text] [Related]
15. Reply to S. Alanee et al.
Fung C; Fossa SD; Milano MT; Sahasrabudhe DM; Peterson DR; Travis LB
J Clin Oncol; 2016 Apr; 34(11):1285-6. PubMed ID: 26858338
[No Abstract] [Full Text] [Related]
16. Long-term sexual functioning in germ-cell tumor survivors.
Chovanec M; Vasilkova L; Petrikova L; Obertova J; Palacka P; Rejlekova K; Sycova-Mila Z; Kalavska K; Svetlovska D; Mladosievicova B; Mardiak J; Mego M
BMC Cancer; 2020 Aug; 20(1):779. PubMed ID: 32819309
[TBL] [Abstract][Full Text] [Related]
17. Testicular germ cell tumours.
Rajpert-De Meyts E; McGlynn KA; Okamoto K; Jewett MA; Bokemeyer C
Lancet; 2016 Apr; 387(10029):1762-74. PubMed ID: 26651223
[TBL] [Abstract][Full Text] [Related]
18. Germ Cell Cancer and Multiple Relapses: Toxicity and Survival.
Lauritsen J; Kier MG; Mortensen MS; Bandak M; Gupta R; Holm NV; Agerbaek M; Daugaard G
J Clin Oncol; 2015 Oct; 33(28):3116-23. PubMed ID: 26240225
[TBL] [Abstract][Full Text] [Related]
19. Progressive resistance training and cancer testis (PROTRACT) - efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial.
Christensen JF; Andersen JL; Adamsen L; Lindegaard B; Mackey AL; Nielsen RH; Rørth M; Daugaard G
BMC Cancer; 2011 Aug; 11():326. PubMed ID: 21806789
[TBL] [Abstract][Full Text] [Related]
20. Testicular cancer survivorship: research strategies and recommendations.
Travis LB; Beard C; Allan JM; Dahl AA; Feldman DR; Oldenburg J; Daugaard G; Kelly JL; Dolan ME; Hannigan R; Constine LS; Oeffinger KC; Okunieff P; Armstrong G; Wiljer D; Miller RC; Gietema JA; van Leeuwen FE; Williams JP; Nichols CR; Einhorn LH; Fossa SD
J Natl Cancer Inst; 2010 Aug; 102(15):1114-30. PubMed ID: 20585105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
